Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Amicus Therapeutics, Inc. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $1.7 Million - $2.21 Million	-129,600 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $1.78 Million - $2.22 Million	129,600 New	129,600 $1.95 Million

Others Institutions Holding FOLD

# of Institutions

310

Shares Held

312M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$278 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$270 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$235 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$231 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$223 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account